Pallas Capital Advisors LLC Has $74,000 Stock Holdings in Blend Labs, Inc. $BLND

Pallas Capital Advisors LLC raised its holdings in Blend Labs, Inc. (NYSE:BLND) by 47.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 22,328 shares of the company’s stock after purchasing an additional 7,194 shares during the quarter. Pallas Capital Advisors LLC’s holdings in Blend Labs were worth $74,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of Blend Labs by 4.6% in the 1st quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock valued at $58,915,000 after purchasing an additional 775,091 shares in the last quarter. Metavasi Capital LP boosted its holdings in shares of Blend Labs by 15.6% during the 1st quarter. Metavasi Capital LP now owns 5,554,101 shares of the company’s stock valued at $18,606,000 after acquiring an additional 750,000 shares in the last quarter. EdgePoint Investment Group Inc. boosted its holdings in shares of Blend Labs by 28.2% during the 1st quarter. EdgePoint Investment Group Inc. now owns 3,318,924 shares of the company’s stock valued at $11,118,000 after acquiring an additional 729,512 shares in the last quarter. Next Century Growth Investors LLC boosted its holdings in shares of Blend Labs by 1.6% during the 1st quarter. Next Century Growth Investors LLC now owns 1,521,648 shares of the company’s stock valued at $5,098,000 after acquiring an additional 23,777 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its holdings in shares of Blend Labs by 36.0% during the 1st quarter. Acadian Asset Management LLC now owns 1,430,949 shares of the company’s stock valued at $4,788,000 after acquiring an additional 378,667 shares in the last quarter. Institutional investors and hedge funds own 52.56% of the company’s stock.

Insider Transactions at Blend Labs

In other Blend Labs news, insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $2.87, for a total transaction of $71,750.00. Following the completion of the transaction, the insider owned 696,598 shares in the company, valued at approximately $1,999,236.26. The trade was a 3.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nima Ghamsari sold 311,886 shares of Blend Labs stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $2.90, for a total value of $904,469.40. Following the transaction, the insider owned 5,754,051 shares of the company’s stock, valued at $16,686,747.90. This trade represents a 5.14% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 421,886 shares of company stock valued at $1,270,769 in the last quarter. Company insiders own 35.52% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Wall Street Zen raised Blend Labs from a “sell” rating to a “hold” rating in a report on Sunday, August 17th. JMP Securities reissued a “market outperform” rating and set a $7.00 price objective on shares of Blend Labs in a report on Wednesday, May 28th. Canaccord Genuity Group reissued a “buy” rating and set a $5.25 price objective on shares of Blend Labs in a report on Friday, August 22nd. UBS Group cut their price objective on Blend Labs from $4.00 to $3.50 and set a “neutral” rating on the stock in a report on Friday, August 8th. Finally, Keefe, Bruyette & Woods cut their price objective on Blend Labs from $4.00 to $3.75 and set a “market perform” rating on the stock in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $4.88.

Blend Labs Price Performance

Shares of Blend Labs stock opened at $4.05 on Tuesday. Blend Labs, Inc. has a one year low of $2.63 and a one year high of $5.53. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of -26.96 and a beta of 1.25. The business has a 50-day simple moving average of $3.58 and a 200 day simple moving average of $3.47.

Blend Labs (NYSE:BLND) last issued its earnings results on Thursday, August 7th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.05). The company had revenue of $31.52 million during the quarter, compared to analyst estimates of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. On average, sell-side analysts expect that Blend Labs, Inc. will post -0.19 EPS for the current year.

Blend Labs Company Profile

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.